top of page
Search
Orasis Pharmaceuticals Announces Licensing Agreement with Optus Pharmaceuticals for Commercialization of Qlosi™
October 16, 2024 Exclusive Agreement Includes $18 Million in Milestone Payments to Orasis, Together with a Double-Digit Royalty on Sales...
SBIJI Innovation
Mar 52 min read
15 views
0 comments
Secret Double Octopus Secures Strategic Investment from SBI Holdings to Propel Global Expansion of Workforce Passwordless Authentication
October 29, 2024 MENLO PARK, Calif.–( BUSINESS WIRE )–Secret Double Octopus, the market leader in workforce passwordless authentication,...
SBIJI Innovation
Mar 51 min read
3 views
0 comments
ImmunoBrain Checkpoint Awarded $5 Million US NIA Grant for Phase 1b Alzheimer’s Disease
ImmunoBrain Checkpoint Awarded $5 Million US NIA Grant for Phase 1b Alzheimer’s Disease Proof-of-Mechanism Study of Anti-PD-L1 IBC-Ab002...
SBIJI Innovation
Aug 29, 20211 min read
49 views
0 comments
Advaxis and Biosight Announce Entry into Definitive Merger Agreement
MONMOUTH JUNCTION, N.J. and AIRPORT CITY, Israel, July 06, 2021 (GLOBE NEWSWIRE) -- Advaxis, Inc. (“Advaxis”) (NASDAQ: ADXS) and Biosight...
SBIJI Innovation
Jul 6, 20211 min read
61 views
0 comments
LogicBio Announces First Patient Dosed in Groundbreaking Phase 1/2 SUNRISE Clinical Trial
LogicBio Therapeutics Announces First Patient Dosed in Groundbreaking Phase 1/2 SUNRISE Clinical Trial for the Treatment of Pediatric...
SBIJI Innovation
Jun 13, 20211 min read
39 views
0 comments
bottom of page